GWSG
IBRX icon

GPS Wealth Strategies Group’s ImmunityBio IBRX Stock Holding History

GPS Wealth Strategies Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,655
Closed -$4.07K – 1015
2025
Q3 		$4.07K Hold
1,655
– – ﹤0.01% 1306
2025
Q2 		$4.37K Hold
1,655
– – ﹤0.01% 1236
2025
Q1 		$4.98K Hold
1,655
– – ﹤0.01% 1152
2024
Q4 		$4.24K Hold
1,655
– – ﹤0.01% 1123
2024
Q3 		$6.16K Hold
1,655
– – ﹤0.01% 1049
2024
Q2 		$10.5K Buy
+1,655
New +$10.9K ﹤0.01% 906

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

GPS Wealth Strategies Group's IBRX Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of ImmunityBio (IBRX) in Q4 2025, closing a stake of 1,655 shares — an estimated $4.07K sold.

GPS Wealth Strategies Group first reported a position in IBRX in Q2 2024 and held it in 6 quarters. The position peaked at $10.5K in Q2 2024. 276 funds tracked by Wall St. Rank hold IBRX as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining ImmunityBio position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 1,655 ImmunityBio shares in Q4 2025, an estimated $4.07K.
  • GPS Wealth Strategies Group first reported a position in ImmunityBio in Q2 2024 and held it in 6 quarters.
  • GPS Wealth Strategies Group's ImmunityBio position peaked at $10.5K in Q2 2024.
  • 276 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.